Summer is finally here (although we’re predicted to have overnight frost this weekend, just in time to kill all the new plants). Anyway, some recent updates from the lab’ and elsewhere…
PeerJ is now on PubMed, which means our paper is now listed!
If anyone knows how to fix a fatal error #323 on a Spectramax Gemini plate reader (tray is not positioning correctly, so it shoots a lamp-failure error), please let me know. We tried a new lamp and that didn’t work.
Apparently NIH director Francis Collins is requesting researchers to post their personal experiences of the impact of the federal budget sequester on Twitter. Please keep it civil.
URMC is dropping server access for IMAP and POP3 this month, which sucks if you use a desktop email client that doesn’t support Outlook protocols. I found a workaround called DavMail, and wrote a guide to implementing it here.
Our AJP Heart paper on mitochondrial KATP channels is now out.
Paul & Sergiy will be headed to the AHA BCVS meeting in July.
And lastly, congrat’s to our colleague Jola Skalska, who will be taking up a faculty position at Alfred University this fall.
After quite possibly the worst set of peer review problems in recent memory, beginning last July, including rejection from 3 separate journals (in one case after 4 months and 2 rounds of review), our “paper from hell” is finally out in PeerJ.
It’s a neat story in which we show that the cardioprotective drugs NS1619 and NS11021, which were always thought to work via a Slo1 BK channel inside cardiac myocyte mitochondria, are instead protecting via activation of a Slo1 channel in intrinsic cardiac neurons. This opens up a whole new area for cardioprotection – namely the idea that saving the cardiac neurons can protect the myocytes against ischemic injury.
The PeerJ thing is pretty cool too – for those who don’t know, it’s a brand-new open acces journal, founded along the same lines as PLoS, but instead of a ridiculous $1500 fee, you join as a lifetime member for $100 and just publish away. All-told, my lab’ has spent ~$8000 on publication fees in the past year, so this new approach is VERY welcome!
Our paper on mitochondrial complex II, and how it is mechanistically linked with the mitochondrial ATP-sensitive potassium channel, is now out (here) as part of an upcoming BBA special issue on complex II. Personally, I think Figure 4 is a work of art.
Our review in Circ. Res., on mitochondrial drugs and cardiac ischemia, is now out.
Its official, I am “over the hill” (40 this month). Status as a junior investigator is long gone. But hey – that means only another 25 years (5-6 grant renewal cycles) until retirement!